dsm-firmenich receives FDA approval for PARSOL® Shield in the U.S
The approval is the first new sunscreen active ingredient in the US in over 25 years, enabling next-generation UV protection.
See the latest news and media coverage for dsm-firmenich. We track all announcements, press releases, and industry mentions in real time, all in one place.
Nutrition, health, and beauty science company
dsm-firmenich.comLast updated
In short: dsm-firmenich divested its Animal Nutrition & Health unit for €2.2 billion, launched a major share buyback, and achieved dual listing in Switzerland.
The approval is the first new sunscreen active ingredient in the US in over 25 years, enabling next-generation UV protection.
The dual listing strengthens capital markets presence in Switzerland and broadens access to Swiss institutional investors.
The company bought back 261,000 shares worth €17.7 million, part of a €540 million program to reduce capital and cover share plans.
During May 4-6, 2026, it repurchased 120,000 shares at €65.45 average price.
DSM-Firmenich AG received a Sell rating and price target from Goldman Sachs analyst Georgina Fraser CFA on June 12. The company's shares closed today at...
"It's really expensive and time consuming," Dobos says. The European company DSM-Firmenich spent at least $18 million over more than two decades in its push...
dsm-firmenich, innovators in nutrition, health, and beauty, announced on February 9, 2026 its intention to repurchase ordinary shares with an aggregate market value of €500...
DSM-Firmenich made its debut on the Swiss exchange on Thursday after the flavours and fragrances maker completed the second part of its dual listing.
Track dsm-firmenich and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to dsm-firmenich and other trending companies.